Turning Point Brands (TPB) saw its stock surge 9.92% in pre-market trading on Wednesday, following the release of its impressive first-quarter 2025 financial results. The company, known for its tobacco and alternative products, significantly outperformed market expectations, driving investor enthusiasm.

The quarterly report revealed that Turning Point's sales reached $106.436 million, handily beating the analyst consensus estimate of $95.8 million by 11.16%. This represents a robust 9.66% increase compared to the same period last year. The company's adjusted earnings per share (EPS) came in at $0.91, surpassing the expected $0.78 by 16.67% and showing a 13.75% year-over-year growth.

Adding to the positive sentiment, Turning Point reaffirmed its 2025 Adjusted EBITDA guidance of $108.0 - $113.0 million, demonstrating confidence in its full-year performance. The company also provided an outlook for its full-year nicotine pouch sales, projecting between $80.0 - $95.0 million, indicating strong growth potential in this segment. These factors combined to fuel investor optimism, leading to the significant pre-market stock price increase.